GPT Healthcare Ltd
GPT Healthcare Ltd (GPTHEALTH) last reported results for the quarter ended Jun 2026, with sales of ₹126 crore and net profit of ₹13 crore. The stock last traded at ₹148, a market capitalisation of ₹1,214 crore, on a P/E of 25.7. Over the past 52 weeks the stock has ranged between ₹114 and ₹175. Figures are as of 6 Oct 2026 and are not real time.
GPT Healthcare Ltd share price and key metrics
- Current price
- ₹148
- Market cap
- ₹1,214 cr
- Stock P/E
- 25.7
- Book value
- ₹32.8
- ROE
- 16.7%
- ROCE
- 19.9%
- Dividend yield
- 1.67%
- 52w high / low
- 175/114
Metrics as of 6 Oct 2026. Not real time.
Track GPT Healthcare Ltd
Cruxal reads every GPT Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
GPT Healthcare Ltd growth and returns
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 9%
- TTM
- 18%
- 10 Years
- %
- 5 Years
- 16%
- 3 Years
- 4%
- TTM
- -1%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -2%
- 10 Years
- %
- 5 Years
- 22%
- 3 Years
- 21%
- Last Year
- 17%
GPT Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹126 cr, up 17.8% from ₹107 cr a year earlier. Net profit was ₹13 cr, up 62.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 106 | 102 | 101 | 107 | 119 | 120 | 126 | 126 |
| Expenses | 82 | 81 | 81 | 90 | 96 | 99 | 103 | 102 |
| Operating profit | 23 | 21 | 21 | 17 | 23 | 21 | 23 | 24 |
| OPM % | 22% | 21% | 20% | 16% | 19% | 17% | 18% | 19% |
| Other income | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| Interest | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 |
| Profit before tax | 21 | 18 | 16 | 11 | 15 | 13 | 16 | 17 |
| Tax % | 28% | 30% | 21% | 31% | 30% | 27% | 8% | 26% |
| Net profit | 15 | 12 | 13 | 8 | 11 | 9 | 15 | 13 |
| EPS (₹) | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 | 1.55 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
GPT Healthcare Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 243 | 337 | 361 | 400 | 407 | 473 | 492 |
| Operating profit | 36 | 49 | 74 | 74 | 88 | 83 | 85 | 91 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 20% | 18% | 19% |
| Net profit | 11 | 21 | 42 | 39 | 48 | 50 | 42 | 47 |
| EPS (₹) | 6.11 | 11.76 | 5.21 | 4.88 | 5.82 | 6.08 | 5.15 | 5.76 |
TTM is the trailing twelve months to the most recent quarter.
GPT Healthcare Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 18 | 18 | 80 | 80 | 82 | 82 | 82 |
| Reserves | 109 | 116 | 78 | 85 | 136 | 166 | 187 |
| Borrowings | 157 | 166 | 102 | 82 | 31 | 35 | 91 |
| Other liabilities | 25 | 18 | 63 | 79 | 96 | 101 | 104 |
| Total liabilities | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
| Fixed assets | 226 | 220 | 220 | 228 | 224 | 228 | 342 |
| CWIP | 2 | 0 | 1 | 3 | 6 | 46 | 1 |
| Investments | 1 | 1 | 10 | 13 | 30 | 32 | 43 |
| Other assets | 80 | 97 | 92 | 83 | 85 | 78 | 79 |
| Total assets | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
As reported by the company. Total assets equal total liabilities by construction.
GPT Healthcare Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 41 | 43 | 66 | 66 | 69 | 67 | 81 |
| Cash from investing | -54 | -16 | -5 | 5 | -25 | -33 | -47 |
| Cash from financing | 12 | -22 | -57 | -73 | -48 | -35 | -31 |
| Net cash flow | -1 | 4 | 3 | -2 | -5 | -0 | 2 |
| Free cash flow | -5 | 38 | 59 | 58 | 50 | 18 | 40 |
| CFO / operating profit | 116% | 88% | 107% | 103% | 95% | 101% | 110% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
GPT Healthcare Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 14% | 23% | 25% | 30% | 27% | 20% |
| Debtor days | 30 | 26 | 15 | 21 | 22 | 18 | 16 |
| Inventory days | 60 | 41 | 30 | 43 | 36 | 41 | 43 |
| Days payable | 314 | 165 | 121 | 161 | 165 | 161 | 170 |
| Cash conversion cycle | -224 | -98 | -76 | -97 | -106 | -102 | -112 |
| Working capital days | -4 | 32 | 3 | -18 | -16 | -28 | -29 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
GPT Healthcare Ltd shareholding pattern
Promoters held 65.57% at Jun 2026, broadly unchanged since Jun 2025. FIIs 3.03% and DIIs 6.94%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% |
| FIIs | 4.70% | 4.71% | 4.49% | 4.96% | 3.20% | 2.73% | 2.81% | 3.03% |
| DIIs | 10.80% | 11.30% | 11.35% | 9.33% | 6.45% | 6.20% | 6.84% | 6.94% |
| Public | 18.92% | 18.41% | 18.59% | 20.14% | 24.77% | 25.48% | 24.79% | 24.46% |
| No. of shareholders | 74,737 | 70,147 | 68,365 | 67,060 | 67,617 | 66,626 | 64,075 | 62,454 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
GPT Healthcare Ltd corporate filings
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Please find enclosed herewith the certificate under regulation 74(5) of SEBI (DP)…
Read the full analysis - Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: Please find enclosed intimation for closure of Trading Window w.e.f October 1, 2026.
Read the full analysis - GPT Healthcare Ltd schedules analyst/investor meeting for September 28, 2026Company Updatelow impact
Cruxal's analysis: GPT Healthcare Ltd has issued a formal intimation regarding an analyst and investor…
Read the full analysis - GPT Healthcare Q1 FY27 Earnings Call: Strong Financial Growth Driven by Improved Specialty Mix and Operational EfficiencyCompany Updatehigh impact
Cruxal's analysis: GPT Healthcare Limited reported a strong Q1 FY27 performance with total income growth of…
Read the full analysis - GPT Healthcare Limited Announces Successful Conclusion of 37th AGM and Approval of Dividend PayoutAGM/EGMlow impact
Cruxal's analysis: GPT Healthcare Limited has successfully concluded its 37th Annual General Meeting, with…
Read the full analysis - GPT Healthcare Limited concludes 37th AGM; confirms total dividend payout of INR 2.50 per share for FY 2025-26AGM/EGMlow impact
Cruxal's analysis: GPT Healthcare Limited has successfully concluded its 37th Annual General Meeting, where…
Read the full analysis - GPT Healthcare releases audio recording of Q1 FY27 earnings call, confirms no new price-sensitive information disclosedCompany Updatelow impact
Cruxal's analysis: GPT Healthcare Limited has announced the availability of the audio recording for its…
Read the full analysis - GPT Healthcare publishes Q1FY2027 Unaudited Financial Results in newspapersCompany Updatelow impact
Cruxal's analysis: GPT Healthcare Ltd. announced the newspaper publication of its Unaudited Financial…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.